Shiho Ishizuka

Association of Probiotic <i>Clostridium butyricum</i> Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer

Yusuke Tomita, Tokunori Ikeda, Shinya Sakata et al. · Cancer Immunology Research · 2020 · 241 citations

Medicine, Immunology, Oncology +15

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Ryo Sato, Kosuke Imamura, Shinya Sakata et al. · Journal of Clinical Medicine · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma

Eri Matsubara, Yoshihiro Komohara, Shigeyuki Esumi et al. · Cancers · 2022 · 72 citations · Full text

Medicine, Cell Biology, Oncology +17

The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma

Yusuke Shinchi, Shiho Ishizuka, Yoshihiro Komohara et al. · Cancer Immunology Immunotherapy · 2022 · 51 citations · Full text

Medicine, Immunology, Oncology +16

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression

Shiho Ishizuka, Shinya Sakata, Chieko Yoshida et al. · Respiratory Investigation · 2018 · 23 citations

Medicine, Oncology, Pharmacology +15